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Abstract: Coffee is one of the most widely consumed drinks around the world, while depression is
considered the major contributor to the overall global burden of disease. However, the investigation
on coffee consumption and depression is limited and results may be confounded by the overall dietary
pattern. We assessed the relationship between coffee intake and the risk of depression, controlling for
adherence to the Mediterranean diet. We studied 14,413 university graduates of the ‘Seguimiento
Universidad de Navarra’ (SUN) cohort, initially free of depression. We evaluated coffee consumption
using a validated food-frequency questionnaire (FFQ). Incident depression cases were adjudicated
only if the participant met two criteria simultaneously: (a) validated physician-diagnosed depression
together with (b) new onset of habitual antidepressant use. Both criteria were needed; participants
meeting only one of them were not classified as cases. Participants who drank at least four cups of
coffee per day showed a significantly lower risk of depression than participants who drank less than
one cup of coffee per day (HR: 0.37 (95% CI 0.15–0.95)). However, overall, we did not observe an
inverse linear dose–response association between coffee consumption and the incidence of depression
(p for trend = 0.22).
Keywords: coffee; depression; cohort study
1. Introduction
Depression is considered the major contributor to the overall global burden of disease and a
common cause of disability worldwide, with more than 300 million people affected [1]. Severe forms of
depression can lead to suicide, which is the second leading cause of death in people aged 15–29 years,
accounting for 800,000 deaths every year [2]. The lifetime prevalence of depression and the distribution
of suicide rates are not uniform. Within Europe, both depression prevalence and suicide rates are
higher in northern countries than in southern ones [3]. Nowadays, the prevention of depression
represents a public health priority due to its huge social and economic burden.
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Some investigations suggest that underlying pathophysiological mechanisms in depression are
also present in metabolic syndrome (MetS), obesity, and cardiovascular disease (CVD) [4]. Endothelial
dysfunction and an increased production of proinflammatory cytokines may explain the link between
depression and CVD [5,6].
On the other hand, coffee is one of the most widely consumed beverages around the world.
It is known that coffee contains antioxidant substances with potentially beneficial properties; e.g.,
chlorogenic acid, flavonoids, melanoidins, and various lipid-soluble compounds such as furans,
pyrroles, and maltol [7].
Two recent meta-analyses including three longitudinal and five cross-sectional studies found
an inverse association between coffee consumption and depression [8,9]. It is noteworthy that none
of the longitudinal studies adjusted their estimates for an overall dietary pattern. Given that coffee
consumption may be associated with a high-quality overall dietary pattern and that a healthy dietary
pattern, such as the traditional Mediterranean diet (MedDiet), has been associated with a lower risk of
depression [10], the overall dietary pattern may be a potential confounder in the association between
coffee consumption and depression. Therefore, it is interesting to assess the association between coffee
consumption and the risk of depression once adherence to an overall healthy dietary pattern has been
accounted for in the analysis. This seems especially relevant when the association is assessed in a
Mediterranean setting.
To our knowledge, the effect of coffee on the risk of depression has not been assessed in a
Mediterranean cohort and it has neither been assessed if coffee consumption can show an inverse
association with depression incidence once adherence to the traditional MedDiet has been accounted for.
Thus, the aim of this study was to evaluate whether coffee consumption is independently associated
with the risk of depression in the SUN project, a prospective cohort of Spanish graduates, after
controlling for adherence to the traditional MedDiet.
2. Materials and Methods
2.1. Study Population
The “Seguimiento Universidad de Navarra” (SUN) project is a prospective multipurpose cohort
of Spanish university graduates. The study methods have been described in more detail elsewhere [11].
Briefly, the SUN project is a dynamic cohort assessing the relationship between diet and chronic
diseases. It was developed inspired by the models of the Nurses’ Health Study and the Health
Professionals Follow-Up Study. Recruitment started in December 1999 and is permanently open.
After the initial questionnaire, follow-up questionnaires are mailed every other year to participants to
update information on diet and lifestyle and collect information on health outcomes which might have
happened in the previous two years. For participants lost to follow-up, the National Death Index is
consulted periodically to assess their vital status. Participants are middle-aged university graduates
from different Spanish regions.
By 2017, 22,564 participants were recruited. In order to allow the minimal follow-up of two
years, we included only those participants who were recruited before March 2014 (2.75 years before
the database closing date). Out of 22,279 eligible subjects, we excluded 1990 participants with no
follow-up information (retention rate 91%); 1910 participants with total energy intake out of predefined
limits (<500 or >3500 kcal/day for women and <800 or >4000 kcal/day for men); participants with
previously diagnosed cardiovascular diseases, cancer, or diabetes (n = 1798); participants who died
before returning their first follow-up questionnaire (n = 39); participants with baseline depression,
regular antidepressant use, or implausible date or depression diagnosis (n = 1811); as well as patients
with diagnosed depression during the first 2 years of follow-up or regular antidepressant use at 2
years of follow-up (n = 318). The final sample consisted of 14,413 participants who answered at least 1
follow-up questionnaire.
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2.2. Assessment of Coffee Consumption
The baseline questionnaire included a previously validated 136-item food-frequency questionnaire
(FFQ) [12–14]. The serving size for coffee was 50 cc. Information about the consumption of regular
and decaffeinated coffee was gathered separately. The FFQ assessed regular food consumption over
the previous 12 months and included nine categories of response for the frequency of consumption,
ranging from ‘never/seldom’ to ‘more than six times per day’. Then, participants were grouped in four
categories according to their level of coffee consumption (<1 cup/day, 1 cup/day, >1–<4 cups/day, ≥4
cups/day).
2.3. Case Ascertainment
We adjudicated an incident case of major depressive disorder during follow-up in a participant
initially free of any history of depression only if he or she met 2 criteria simultaneously: (a) a
validated [15] self-reported new physician-made diagnosis of depression together with (b) new-onset
habitual use of antidepressants (in the previous 2 years). Both criteria were needed; participants
meeting only one of them were not classified as cases.
2.4. Assessment of Covariates
Sociodemographic, anthropometric, lifestyle, and comorbidity information were also collected
at baseline and updated every two years through the follow-up questionnaires. The adherence to
the MedDiet was established based on the information in the FFQ according to the index defined by
Trichopoulou et al. [16]. The latest available information on food composition tables for Spain was
utilized by trained dietitians to update the nutrient dataset from the information collected with the
FFQ. The baseline questionnaire also included three questions on self-perceived personality traits with
scores ranging from 0 to 10. More concretely, these questions assessed self-perceived psychological
dependence (0—autonomous to 10—dependent), competitiveness (0—conformist to 10—competitive)
and anxiety (0—relaxed to 10—tense) [17].
2.5. Statistical Analysis
Baseline quantitative traits of participants were described as the mean and standard deviation
according to categories of coffee consumption and baseline qualitative traits, and as the percentage
across the same categories. We calculated p values for comparisons across categories of
coffee consumption with ANOVA for quantitative variables and with chi-squared tests for
qualitative variables.
Cox regression models were fit to assess the association between coffee intake and the risk of
clinical depression development. We used age as the underlying time variable in all the analyses.
Models were stratified by age and period of completion of baseline questionnaire. Participants
contributed to the person-years of follow-up from the study inception until diagnosis of depression,
death, or last follow-up questionnaire; whichever occurred first.
In our main analysis, we used total coffee intake as the exposure variable. The group in the lowest
level of coffee consumption was used as the reference category in all the analyses. For the linear trend
test, the median in each category of coffee consumption was calculated to generate a new quantitative
variable. As a sensitivity analysis, we also fit models for regular and decaffeinated coffee separately.
The final model was adjusted for potential confounders such as sex, body-mass index (BMI;
3 categories), physical activity (continuous), alcohol intake (linear and quadratic), smoking status
(never/former/current/missing) and package-years of smoking (continuous), total energy intake
(continuous), adherence to the traditional MedDiet (continuous), years of university studies
(continuous), marital status (3 categories), TV-watching hours (continuous), snacking, following
any special diet, baseline hypertension and baseline hypercholesterolemia, self-perception of
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competitiveness, anxiety, and psychological dependence (continuous), and use of tranquilizers or
anxiolytic drugs, and was stratified for age (decades) and recruitment period.
The interactions of coffee consumption (4 categories) with sex, age (2 categories), and smoking
status (4 categories) were studied by introducing an interaction term in the model and calculating the
likelihood ratio test between the model with the interaction and the model without it.
All analyses were performed with Stata SE 15.0. A two-sided p value below 0.05 was deemed as
statistically significant.
3. Results
We followed 14,413 participants, 5765 (40%) men and 8648 women, for a mean follow-up time of
10 years (standard deviation (SD): 4). Mean age of participants at recruitment was 36.4 years (SD: 11.5).
Among 144,029 person-years follow-up, we identified 199 incident cases of depression. The incidence
rate of depression was 1.3/1000 person-years of follow-up in the lowest category of coffee consumption
and 1.5, 1.5, and 0.8/1000 persons-years of follow-up in the subsequent categories.
Participants’ baseline characteristics by category of coffee consumption are shown in Table 1.
On average, participants in the highest category of coffee consumption were older, had a higher
average BMI, and reported higher mean total energy intake, lower physical activity, and being more
tense compared to participants in the lower coffee consumption categories. Those participants were
also more likely to be male, married, current smokers, and to consume more alcohol. At baseline, they
also reported higher blood cholesterol levels and were more prone to be following any special diet
than their peers in the other categories of coffee consumption.
Table 1. Baseline characteristics of participants according to total coffee consumption.
Cups/Day
Total Coffee Consumption
p Value
<1 1 >1 and <4 ≥4
N 5253 2667 5928 565
Age at recruitment 34.5 (11.8) 37.7 (11.9) 37.1 (10.8) 39.5 (11.1) <0.001
Body-mass index (kg/m2) 23.2 (3.4) 23.4 (3.3) 23.5 (3.4) 24.1 (3.7) 0.002
Physical activity in METS 28.7 (26.1) 26.8 (23.9) 25.7 (21.5) 26.4 (24.9) <0.001
Total energy in kcal/day 2292 (630) 2352 (593) 2406 (598) 2479 (653) <0.001
Adherence to Mediterranean diet (0–9 score) 4.04 (1.79) 4.36 (1.82) 4.37 (1.78) 4.37 (1.69) 0.157
Alcohol intake in g/day 5.24 (8.32) 7.08 (10.25) 7.28 (10.13) 8.34 (14.2) <0.001
Years of university education 4.92 (1.48) 5.09 (1.50) 5.13 (1.52) 5.12 (1.58) 0.055
Sex (% male) 41.2 40.1 38.4 45.3 0.001
Snacking (%) 35.8 29.1 32.5 35.4 <0.001
Special diet (%) 6.24 6.60 7.25 9.73 0.007
Hypertension (%) 8.68 9.00 8.11 8.85 0.514
Cholesterol >200 mg/dl (%) 13.0 15.7 16.0 20.2 <0.001
Smoking (%)
Never 59.5 49.5 41.8 28.8
Current 19.4 22.2 29.5 40.4
Former 18.3 25.9 26.4 27.1 <0.001
Marital status (%)
Single 56.1 42.7 44.2 36.5
Married 41.6 54.7 53.1 60.7
Other 2.25 2.55 2.77 2.83 <0.001
Personality traits (range 0–10)
Psychological dependence 3.69 (2.83) 3.49 (2.87) 3.53 (2.81) 3.59 (2.97) 0.236
Competitiveness 6.99 (1.73) 6.96 (1.77) 6.96 (1.70) 7.09 (1.73) 0.086
Anxiety 5.82 (2.22) 5.80 (2.20) 5.91 (2.13) 6.22 (2.19) 0.017
Data are mean (standard deviation), unless otherwise stated.
Table 2 presents hazard ratios (HR) and their 95% confidence intervals (CI) for the risk of
depression in the crude and multivariable adjusted models. In the comparison across extreme
categories of coffee consumption, participants who consumed at least 4 cups of coffee per day showed
a 63% (HR = 0.37, 95% CI 0.15–0.95) lower risk of depression than participants who drank less than
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1 cup of coffee per day. However, overall, we did not observe a linear dose–response association
between coffee consumption and the incidence of depression (p for trend = 0.22).
No significant interaction was found between total coffee consumption and sex, age, or smoking
status in their association with incident depression (p > 0.05 for all of them).
Table 2. Hazard ratios (HR; 95% confidence intervals) for incidence of depression according to baseline
total coffee consumption.
Cups/Day
Total Coffee Consumption
p for Trend
<1 1 >1 and <4 ≥4
Cups/day (median) 0.07 1 2.5 5
N 5253 2667 5928 565
Cases 64 39 91 5
Person-years 51,145 26,065 60,705 6115
Crude HR 1 (ref.) 1.14 (0.76–1.70) 1.12 (0.81–1.55) 0.60 (0.24–1.50) 0.963
Model 1 1 (ref.) 1.12 (0.75–1.67) 1.09 (0.79–1.51) 0.58 (0.23–1.45) 0.923
Model 2 1 (ref.) 1.05 (0.70–1.58) 0.95 (0.68–1.33) 0.37 (0.15–0.95) 0.220
Results from Cox regression models. Age was the underlying time variable in all analyses. Model 1: adjusted for
sex and stratified for age (decades) and recruitment period. Model 2: adjusted for sex, alcohol intake (linear
and quadratic term), years of university education, marital status, smoking, body mass index, total energy
intake, adherence to the Mediterranean diet, between-meal snacking and following special diets, leisure-time
physical activity (METS-h/week), hours of TV watching, hypertension at baseline, baseline high blood cholesterol,
self-perception of competitiveness, anxiety, and psychological dependence, and use of anxiolytics, and stratified for
age (decades) and recruitment period.
In further analyses, we specifically studied regular and decaffeinated coffee consumption (Table 3).
The HR for the risk of depression associated with ≥4 cups per day of regular coffee compared to <1
cup per day was 0.44 (95% CI: 0.18–1.11; p for trend = 0.141), in a model adjusted for the consumption
of decaffeinated coffee consumption. On the other hand, decaffeinated coffee consumption was not
associated with the risk of depression in the fully adjusted model.
Table 3. Subgroup analysis. Hazard ratios (95% confidence intervals) for incidence of depression
according to baseline regular and decaffeinated coffee consumption.
Cups/Day
Regular Coffee Consumption
p for Trend
<1 1 >1 and <4 ≥4
Cups/day (median) 0 1 2.5 5
N 6315 3433 4193 472
Cases 84 49 61 5
Person-years 61,621 34,065 43,130 5212
Crude HR 1 (ref.) 1.01 (0.71–1.44) 0.97 (0.69–1.35) 0.65 (0.26–1.60) 0.569
Model 1 1 (ref.) 1.00 (0.70–1.42) 0.96 (0.69–1.34) 0.64 (0.26–1.59) 0.533
Model 2 1 (ref.) 0.96 (0.67–1.37) 0.84 (0.59–1.18) 0.43 (0.17–1.07) 0.095
Additionally adjusted for
decaffeinated coffee consumption 1 (ref.) 0.97 (0.68–1.39) 0.87 (0.61–1.23) 0.44 (0.18–1.11) 0.141
Cups/day
Decaffeinated Coffee Consumption
p for Trend
<1 1 >1
Cups/day (median) 0 1 2.5
N 12,700 1268 445
Cases 167 21 11
Person-years 127,007 12,674 4348
Crude HR 1 (ref.) 1.25 (0.79–1.96) 1.90 (1.03–3.51) 0.033
Model 1 1 (ref.) 1.20 (0.76–1.89) 1.77 (0.96–3.26) 0.065
Model 2 1 (ref.) 1.20 (0.76–1.89) 1.54 (0.82–2.87) 0.142
Additionally adjusted for
regular coffee consumption 1 (ref.) 1.15 (0.72–1.82) 1.46 (0.78–2.76) 0.218
Results from Cox regression models. Age was the underlying time variable in all analyses. Model 1: adjusted
for sex and stratified for age (decades) and recruitment period. Model 2: adjusted for age, sex, alcohol intake
(linear and quadratic term), years of university education, marital status, smoking, body mass index, total energy
intake, adherence to the Mediterranean diet, between-meal snacking and following special diets, leisure-time
physical activity (METS-h/week), hours of TV watching, hypertension at baseline, baseline high blood cholesterol,
self-perception of competitiveness, anxiety, and psychological dependence, and use of anxiolytics.
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4. Discussion
In this study, we found that participants who consumed at least four cups of coffee per day
showed a lower risk of depression than participants who drank less than one cup of coffee per day.
Nevertheless, we found no significant dose–response relationship between coffee consumption and
the risk of depression.
The observed inverse association between extreme categories of coffee consumption is consistent
with previous literature. On the one hand, several cross-sectional studies have assessed this
association [18–22]. Some [18–20], but not all [21,22], found a significant inverse association
between coffee consumption and the risk of depression. However, due to the cross-sectional
design of these studies, reverse causality cannot be ruled out. On the other hand, there are three
prospective studies that have longitudinally assessed the association between coffee consumption
and the risk of depression [23–25]. These three prospective studies have been pooled in two
independent meta-analyses [8,9]. The combined results suggested an inverse association between
coffee consumption and the risk of depression. As far as the setting for the three prospective cohort
studies was concerned, two of them had been conducted in the U.S. [23,24], and another one, including
a smaller number (2232) of participants, in Finland [25]. Individually, the three studies described
an inverse association between coffee consumption and the risk of depression. The strength of
the association was highest in the Finnish cohort, which included only men [25]. In that study,
a 75% reduction in the risk of depression was observed when heavy coffee drinkers were compared
with non-coffee drinkers [25]. Nevertheless, the analyses were based on 73 events. Risk reductions
in the other two cohorts were milder [23,24]. It is worth mentioning that our study had some
differential characteristics with previous prospective studies. First, the mean age of participants
in our cohort was 36 years, whereas the mean age was 53 years in the study by Ruusunen et al. [25],
62 years in the study with data from the NIH-AARP study [24], and 63 years in the Nurses’ Health
Study [23]. Also, in the Finnish study, the outcome was given by a discharge diagnosis of depressive
disorder [25] and our outcome—consistent with the other two studies [22,23]—was ascertained through
self-reported information.
When we separately assessed the association between regular and decaffeinated coffee
consumption and the risk of depression, we found no significant association for decaffeinated coffee
consumption. Out of the three longitudinal studies which have assessed the association between
coffee consumption and depression risk, decaffeinated coffee consumption was associated with a
lower risk of depression (HR ≥ 4 cups/day vs. none = 0.88 (95% CI 0.78–1.00), p for trend = 0.003) in
the NIH-AARP study [24], but no significant association for decaffeinated coffee consumption was
observed in the Nurses’ Health Study [23]. In the Kuopio Ischaemic Heart Disease Risk Factor Study,
decaffeinated coffee consumption was not specifically assessed [25].
In a dose–response meta-analysis on coffee consumption and depression risk, Grosso et al.
observed a nonlinear J-shaped dose–response association with a peak (the lowest observed risk) for
the inverse association at 400 mL/day, which was stable toward a slight increase for higher coffee
consumption [9]. It is worth mentioning that the studies that contributed most—i.e., had a higher
weight—in this meta-analysis had been conducted in the U.S. [23,24], where the typical serving size
is bigger than in Spain. The greatest risk reduction in our study was observed for participants who
consumed at least four cups of coffee per day compared to those who consumed less than one cup per
day, but we were not able to draw conclusions for participants with heavier coffee consumptions.
There are two main hypotheses which could explain the association between the higher coffee
intake and a possible reduction in the risk of depression. First, coffee is the main dietary source
of caffeine. Caffeine is an alkaloid exerting a stimulant effect on the central nervous system and
modulating the dopaminergic activity by nonspecific antagonism against A1/A2 adenosine receptors.
A moderate amount of caffeine has a beneficial effect, improving psychomotor activity, vigilance level,
and increasing the perception of feeling more energetic [26]. Second, coffee has a high concentration of
polyphenols, such as chlorogenic acid and trigonelline, which have anti-inflammatory potential [7].
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Thus, coffee consumption could protect against low-grade inflammation, which seems to be involved
in the pathogenesis of depression [27]. In fact, coffee is the main dietary source of polyphenols [28,29]
in some populations such as the U.S. or Northern Europe, where the other prospective studies on coffee
and depression had been conducted [21–23]. Contrarily, in our cohort (data not shown), as well as in
other Spanish cohorts, fruits—and not coffee—are the primary source of polyphenols [30]. Interestingly,
in the prospective studies conducted so far [23–25], the analyses were not adjusted for an overall
dietary pattern. Only one analysis [24] was adjusted for daily intake of folate and polyunsaturated fatty
acids. Therefore, it was unknown if coffee had the same beneficial effect on participants beyond an
overall healthy dietary pattern. To our knowledge, our study is the first one evaluating the association
between coffee consumption and depression in which adherence to an overall healthy dietary pattern
has been accounted for.
Some limitations of our study should be acknowledged. First, the SUN cohort is not a
representative sample of the general population in the pure statistical sense. However, lack of
representativeness does not preclude from establishing associations [31,32]. These associations can
be generalized to other groups as long as no biological mechanism suggests that the association
no longer holds for other populations. Second, dietary information was self-reported. Therefore,
we cannot exclude some degree of nondifferential misclassification which could have biased our
results more probably towards the null. However, the FFQ has been previously validated [12–14].
Third, due to the strict criteria used for the adjudication of the outcome together with some particular
characteristics of our study participants—such as their high educational level and their high levels
of health-consciousness related to voluntarily participating in a cohort—the incidence of depression
in our cohort may seem relatively low in comparison with other studies. However, when we
included as incident cases all participants with a medical diagnosis of depression, those who were
using antidepressant medication, and the cases that occurred in the two first years, the overall
incidence of depression in the cohort during follow-up was 6% (data not shown). In any case,
this does not necessarily mean a bias in the sample, as Rothman and other methodologists have
repeatedly considered regarding the nonrepresentative nature of most cohorts in the statistical sense
of “representativeness” [32]. Fourth, although all the results were adjusted for potential confounders,
we cannot exclude the presence of some residual confounding factors that could partly explain our
results. Nevertheless, with subsequent adjustment of our models with a wide array of potential
confounders, the association became stronger for total coffee consumption and for regular coffee
consumption. Therefore, we believe it is unlikely that unmeasured confounders could explained
the observed association. Fifth, coffee consumption was assessed only in the baseline questionnaire,
assuming it was maintained over time. Nevertheless, previous studies have suggested that coffee
consumption remains relatively stable over time [33]. Sixth, tea consumption was not very common in
Spain by the time the FFQ was developed, and this item was thus not included in the FFQ. Therefore,
we could not assess the specific association between tea consumption and incident depression.
Several strengths of this study deserve to be mentioned. The prospective longitudinal design of
the study with an extended follow-up period, the relatively large sample size, the validated assessment
of coffee consumption, the validated self-reported medical diagnosis of depression, the ability to
control for a good number of potential confounding factors, and the high retention rate (91%) are
strengths of our study. Additionally, the high educational level of our participants could contribute to
increase the quality of the self-reported information and, thus, reduce the potential for misclassification
bias. Furthermore, the exclusion of participants with a depression diagnosis or use of antidepressant
medication at baseline or before the first two years of follow-up reduced the possibility of reverse
causation bias due to subclinical cases of depression present at baseline. Baseline coffee consumption of
participants with baseline depression or antidepressant use might be a consequence of their condition,
rather than vice versa. Also, participants who were diagnosed during the first two years of follow-up
might have already had some symptoms at the study inception, which might have conditioned
their coffee consumption. Therefore, we excluded participants with self-reported depression or
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antidepressant use during the first two years of follow-up in order to ensure temporal sequence.
Finally, the incident cases were defined as self-reported physician-diagnosed depression together with
commencement of regular antidepressant medication. Self-reported medical diagnosis of depression
showed an acceptable validity in a previous validation study [15]. In the present paper, we increased
the specificity of our outcome by including as an additional criterion the commencement of regular
antidepressant use. This definition is consistent with previous literature in this area [23] and is stricter.
Eventually, this definition might have led to the underestimation of true cases and to a lower sensitivity,
but to a higher specificity. Supposedly, with perfect specificity, the nondifferential sensitivity of disease
detection would not bias the estimate for the relative risk [34].
5. Conclusions
In conclusion, higher coffee consumption was inversely associated with the incidence of
depression in a Mediterranean cohort, although the linear dose–response association was not
significant. Future studies with longitudinal design and intervention studies would be needed to
investigate potential health benefits of coffee consumption.
Author Contributions: Conceptualization, M.Á.M.-G. and E.T.; methodology, M.Á.M-G., A.S.-V., and E.T.;
software, A.M.N., D.A., and E.T.; validation, M.Á.M.-G. and A.S.-V.; formal analysis, A.M.N., D.A., and E.T.;
investigation, E.T. and M.Á.M.-G.; resources, M.Á.M.-G and A.S.-V.; data curation, M.Á.M.-G.; writing—original
draft preparation, A.M.N. and D.A.; writing—review and editing, all authors; visualization, E.T.; supervision, E.T.;
project administration, M.Á.M.-G.; funding acquisition, M.A.Á.-G. and A.S.-V.
Funding: This work was supported by the Spanish Government-Instituto de Salud Carlos III, the European
Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615,
PI14/01668, PI14/01798, PI14/01764, PI17/01795, and G03/140), the Navarra Regional Government (45/2011,
122/2014), and the University of Navarra.
Acknowledgments: The authors are indebted to the participants of the SUN study for their continued cooperation
and participation. We are also grateful to the members of the Department of Nutrition of the Harvard School
of Public Health (Willett W.C., Hu F.B., and Ascherio A.) who helped us to design the SUN study. We also
thank the other members of the SUN Group: Alonso A., Barrio López M.T., Basterra-Gortari F.J., Benito Corchón
S., Bes-Rastrollo M., Beunza J.J., Carlos S., Carmona L., Cervantes S., de Irala J., de la Fuente-Arrillaga C.,
de la Rosa P.A., Delgado-Rodríguez M., Donat-Vargas C., Donázar M., Eguaras S., Fernández-Montero A., Galbete
C., García-López M., Gea A., Goñi Ochandorena E., Guillén Grima F., Hernández-Hernández A., Lahortiga F.,
Llorca J., López del Burgo C., Marí Sanchís A., Martí del Moral A., Martínez J.A., Núñez-Córdoba J.M., Pimenta
A.M., Ramallal R., Rico A., Ruiz-Zambrana A., Ruiz-Canela M., Sánchez Adán D., Sayón-Orea C., Vázquez Ruiz
Z., and Zazpe García I.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Bromet, E.; Andrade, L.H.; Hwang, I.; Sasmpson, N.A.; Alonso, J.; de Girolamo, G.; de Graaf, R.;
Demyttenaere, K.; Hu, C.; Iwata, N.; et al. Cross-national epidemiology of DSM-IV major depressive
episode. BMC Med. 2011, 9, 90. [CrossRef] [PubMed]
2. World Health Organization. Depression. Global Health Observatory (GHO) Data. Available online: http:
//www.who.int/news-room/fact-sheets/detail/depression (accessed on 21 May 2018).
3. Chishti, P.; Stone, D.H.; Corcoran, P.; Williamson, E.; Petridou, E. EIROSAVE Working Group. Suicide
mortality in the European Union. Eur. J. Public Health 2003, 13, 108–114. [PubMed]
4. Perez-Cornago, A.; de la Iglesia, R.; Lopez-Legarrea, P.; Abete, I.; Navas-Carretro, S.; Lacunza, C.I.;
Lahortiga, F.; Martinez-Gonzalez, M.A.; Martinez, A.; Zulet, M.A. A decline in inflammation is associated
wigh less depressive symptoms after a dietary intervention in metabolic syndrome patients: A longitudinal
study. Nutr. J. 2014, 13, 36. [CrossRef] [PubMed]
5. Daly, M. The Relationship of C-Reactive Protein to Obesity-Related Depressive Symptoms: A Longitudinal
Study. Obesity 2013, 21, 248–250. [CrossRef] [PubMed]
6. Morris, A.A.; Ahmed, Y.; Stoyanova, N.; Hooper, W.C.; De STaerke, C.; Gibbons, G.; Din-Dzietham, R.;
Quyyumi, A.; Vaccarin, V. The Association between Depression and Leptin is Mediated by Adiposity.
Psychosom. Med. 2012, 74, 483–488. [CrossRef] [PubMed]
Nutrients 2018, 10, 1333 9 of 10
7. Godos, J.; Pluchinotta, F.R.; Marventano, S.; Buscemi, S.; Volti, G.L.; Galvano, F.; Grosso, G. Coffee
components and cardiovascular risk: Beneficial and detrimental effects. Int. J. Food Sci. Nutr. 2014,
65, 925–936. [CrossRef] [PubMed]
8. Wang, L.; Shen, X.; Wo, Y.; Zhang, D. Coffee and caffeine consumption and depression: A meta-analysis of
observational studies. Aust. N. Z. J. Psychiatry 2016, 50, 228–242. [CrossRef] [PubMed]
9. Grosso, G.; Micek, A.; Castellano, S.; Pajak, A.; Galvano, F. Coffee, tea, caffeine and risk of depression:
A systematic review and dose-response meta-analysis of observational studies. Mol. Nutr. Food Res. 2016,
60, 223–234. [CrossRef] [PubMed]
10. Sánchez-Villegas, A.; Delgado-Rodríguez, M.; Alonso, A.; Schlatter, J.; Lahortiga, F.; Serra Majem, L.;
Martínez-González, M.A. Association of the Mediterranean dietary pattern with the incidence of
depression: The Seguimiento Universidad de Navarra /University of Navarra Follow-up (SUN)
Cohort. Arch. Gen. Psychiatry 2009, 66, 1090–1098. [CrossRef] [PubMed]
11. Carlos, S.; De La Fuente-Arrillaga, C.; Bes-Rastrollo, M.; Razquin, C.; Rico-Campà, A.;
Martínez-González, M.A.; Ruiz-Canela, M. Mediterranean Diet and Health Outcomes in the SUN
Cohort. Nutrients 2018, 10. [CrossRef] [PubMed]
12. Martin-Moreno, J.M.; Boyle, P.; Gorgojo, L.; Maisonneuve, P.; Fernandez-Rodriguez, J.C.; Salvini, S.;
Willett, W.C. Development and validation of a food frequency questionnaire in Spain. Int. J. Epidemiol. 1993,
22, 512–519. [CrossRef] [PubMed]
13. Fernández-Ballart, J.D.; Piñol, J.L.; Zazpe, I.; Corella, D.; Carrasco, P.; Toledo, E.; Perez-Bauer, M.;
Martínez-González, M.A.; Salas-Salvadó, J.; Martín-Moreno, J.M. Relative validity of a semi-quantitative
food-frequency questionnaire in an elderly Mediterranean population of Spain. Br. J. Nutr. 2010,
103, 1808–1816. [CrossRef] [PubMed]
14. De la Fuente-Arrillaga, C.; Ruiz, Z.V.; Bes-Rastrollo, M.; Sampson, L.; Martínez-González, M.A.
Reproducibility of an FFQ validated in Spain. Public Health Nutr. 2010, 13, 1364–1372. [CrossRef] [PubMed]
15. Sanchez-Villegas, A.; Schlatter, J.; Ortuno, F.; Lahortiga, F.; Pla, J.; Benito, S.; Martinez-Gonzalez, M.A.
Validity of a self-reported diagnosis of depression among participants in a cohort study using the Structured
Clinical Interview for DSM-IV (SCID-I.). BMC Psychiatry 2008, 8, 43. [CrossRef] [PubMed]
16. Trichopoulou, A.; Costacou, T.; Bamia, C.; Trichopoulos, D. Adherence to a Mediterranean Diet and Survival
in a Greek Population. Engl. J. Med. 2003, 348, 2599–2608. [CrossRef] [PubMed]
17. Lahortiga-Ramos, F.; Unzueta, C.R.; Zazpe, I.; Santiago, S.; Molero, P.; Sánchez-Villegas, A.;
Martínez-González, M.Á. Self-perceived level of competitiveness, tension and dependency and depression
risk in the SUN cohort. BMC Psychiatry 2018, 18, 241. [CrossRef] [PubMed]
18. Pham, N.M.; Nanri, A.; Kurotani, K.; Kuwahara, K.; Kume, A.; Sato, M.; Hayabuchi, H.; Mizoue, T. Green tea
and coffee consumption is inversely associated with sepressive symptoms in a Japanese working population.
Public Health Nurt. 2013, 17, 625–633. [CrossRef]
19. Park, R.J.; Moon, J.D. Coffee and depression in Korea: The fifth Koreal National Health and Nutrition
Examination Survey. Eur. J. Clin. Nutr. 2014, 69, 501–504. [CrossRef] [PubMed]
20. Omagari, K.; Sakaki, M.; Tsujimoto, Y.; Shiogama, Y.; Iwanaga, A.; Ishimoto, M.; Yamaguchi, A.;
Masuzumi, M.; Kawase, M.; Ichimura, M.; et al. Coffee consumption is inversely associated with depressive
status in Japanes Patients with tipe 2 diabetes. J. Clin. Biochem. Nutr. 2014, 55, 134–142. [CrossRef] [PubMed]
21. Hintikka, J.; Tolmunen, T.; Honkalampi, K.; Haatainen, K.; Koivumaa-Honkanen, H.; Tanskanen, A.;
Viinamäki, H. Daily tea drinking is associated with a low level of depressive symptoms in the Finnish
general population. Eur. J. Epidemiol. 2005, 20, 359–363. [CrossRef] [PubMed]
22. Niu, K.; Hozawa, A.; Kuriyama, S.; Ebihara, S.; Guo, H.; Nakaya, N.; Ohmori-Matsuda, K.; Takahashi, H.;
Masamune, Y.; Asada, M.; et al. Green tea consumption is associated with depressive symptoms in the
elderly. Am. J. Clin. Nutr. 2009, 90, 1615–1622. [CrossRef] [PubMed]
23. Lucas, M.; Mirzaei, F.; Pan, A.; Okereke, O.; Willett, W.; O’Reilly, E.J.; Koenen, K.; Ascherio, A. Coffee,
Caffeine, and Risk of Depression among Women. Arch. Intern. Med. 2011, 171, 1571–1578. [CrossRef]
[PubMed]
24. Guo, X.; Park, Y.; Freedman, N.D.; Sinha, R.; Hollenbech, A.R.; Blair, A.; Chen, H. Sweetened Beverages,
Coffee and Tea and Depression Risk among Older US Adults. PLoS ONE 2014, 9. [CrossRef] [PubMed]
Nutrients 2018, 10, 1333 10 of 10
25. Ruusunen, A.; Lehto, S.M.; Tolmunen, T.; Mursu, J.; Kaplan, G.A.; Voutilainen, S. Coffee, tea and caffeine
intake and the risk of severe depression in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease
Risk Factor Study. Public Health Nutr. 2010, 13, 1215–1220. [CrossRef] [PubMed]
26. Adan, A.; Prat, G.; Fabbri, M.; Sanchez-Turet, M. Early effects of caffeinated and decaffeinated coffee on
subjective state and gender differences. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 1698–1703.
[CrossRef] [PubMed]
27. Sanchez-Villegas, A.; Martinez-González, M.A. Diet, a new target to prevent depression? BMCMed. 2013,
11, 3. [CrossRef] [PubMed]
28. Ovaskainen, M.L.; Törrönen, R.; Koponen, J.M.; Sinkko, H.; Hellström, J.; Reinivuo, H.; Mattila, P. Dietary
intake and major food sources of polyphenols in Finnish adults. J. Nutr. 2008, 138, 562–566. [CrossRef]
[PubMed]
29. Burkholder-Cooley, N.; Rajaram, S.; Haddad, E.; Fraser, G.E.; Jaceldo-Siegl, K. Comparison of polyphenol
intakes according to distinct dietary patterns and food sources in the Adventist Health Study-2 cohort.
Br. J. Nutr. 2016, 115, 2162–2169. [CrossRef] [PubMed]
30. Tresserra-Rimbau, A.; Medina-Remón, A.; Pérez-Jiménez, J.; Martınez-Gonzalez, M.A.; Covas, M.I.;
Corella, D.; Salas-Salvado, J.; Gomez-Gracia, E.; Lapetra, J.; Aros, F.; et al. Dietary intake and major
food sources of polyphenols in a Spanish population at high cardiovascular risk: The PREDIMED study.
Nutr. Metab. Cardiovasc. Dis. 2013, 23, 953–959. [CrossRef] [PubMed]
31. Rothman, K.J.; Gallacher, J.E.; Hatch, E.E. Why representativeness should be avoided. Int. J. Epidemiol. 2013,
42, 1012–1014. [CrossRef] [PubMed]
32. Rothman, K.J. Epidemiology. An Introduction, 2nd ed.; Oxford University Press: New York, NY, USA, 2012.
33. Winkelmayer, W.; Stampfer, M.J.; Willett, W.C.; Curhan, G.C. Habitual Caffeine Intake and the Risk of
Hypertension in Women. JAMA 2005, 294, 2330–2335. [CrossRef] [PubMed]
34. Greenland, S.; Lash, T.L. Bias analysis. In Modern Epidemiology, 3rd ed.; Rothman, K.J., Greenland, S.,
Lash, T.L., Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2008; p. 359.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
